Last reviewed · How we verify
NCT05496361
A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke
NA trial testing Tianyi Revascularization Device in AIS in 238 participants. Completed in 20 July 2022.
24 November 2021
Quick facts
| Lead sponsor | Suzhou Zenith Vascular Scitech Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 238 |
| Start date | 24 January 2021 |
| Primary completion | 24 November 2021 |
| Estimated completion | 20 July 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Tianyi Revascularization Device
- Solitaire FR Revascularization Device
Conditions studied
- AIS — all drugs for AIS →
- Acute Ischemic Stroke — all drugs for Acute Ischemic Stroke →
- Large Vessel Occlusion — all drugs for Large Vessel Occlusion →
- Thrombectomy — all drugs for Thrombectomy →
Sponsor
Suzhou Zenith Vascular Scitech Co., Ltd.
Who can join
Adults 18 to 85, any sex, with AIS or Acute Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, randomized, single blind, concurrent controlled, multi-center study. Patients presenting with symptoms of acute ischemic stroke who have evidence of a large vessel occlusion in the cerebral circulation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05496361
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for AIS
Currently open trials in the same condition.
- NCT05466383 — Screening and Intervention for AIS in Haikou, Hainan Province, China · NA · recruiting
- NCT04422366 — Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females · Phase 3 · recruiting
Other Suzhou Zenith Vascular Scitech Co., Ltd. trials
Trials by the same sponsor.
- NCT05992168 — Stent-Retriever for Acute Massive Pulmonary Embolism (SRAME) · NA · terminated
- NCT05574972 — Timing Carotid Stent Clinical Study for the Treatment of Carotid Artery Stenosis（Timing Trial） · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05496361 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Suzhou Zenith Vascular Scitech Co., Ltd.
- Last refreshed: 11 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05496361.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing